Policy Notices

• NIH Updated Policy Guidance for Subaward/Consortium Written Agreements
  (NOT-OD-23-133)
  National Institutes of Health
  

General Notices

• Notice of NIDCR Participation in PAR-23-156 Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
  (NOT-DE-23-011)
  National Institute of Dental and Craniofacial Research
  

• Notice of Participation of the NICHD in NOT-MD-23-002, "Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations"
  (NOT-HD-23-010)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Participation of the NICHD in NOT-MD-23-003, "Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions"
  (NOT-HD-23-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• NHLBI TOPMed Announces Fellowship Program to Promote Diversity, Equity, and Inclusion in the Genomic Data Science Research Workforce
  (NOT-HL-23-086)
  National Heart, Lung, and Blood Institute
  

• NINDS Announces Plans to Publish the NINDS Rigor Champions Prize Challenge Competition
  (NOT-NS-23-085)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Information: Anticipated Publication of the PHS 2023-2 Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
  (NOT-OD-23-124)
  Office of the Director, NIH
  

• Notice Regarding the Data Management and Sharing Plan for Applications Submitted to PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program and PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models
  (NOT-OD-23-131)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Notice of Changes to Funding Opportunities

• Notice of Participation of the NIAAA in PAR-23-191 "HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)"
  (NOT-AA-23-013)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change to RFA-AG-24-009, "Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)"
  (NOT-AG-23-028)
  National Institute on Aging
  

• Notice to Extend the Expiration Date for RFA-DC-20-002 NIDCD's Mentored Research Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
  (NOT-DC-23-011)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of NEI Participation in RFA-OD-23-050, "Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)"
  (NOT-EY-23-006)
  National Eye Institute
  

• Notice of NEI Participation in RFA-OD-23-051, "Emergency Award: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)"
  (NOT-EY-23-007)
  National Eye Institute
  

• Notice of Correction to Due Date for Letter of Intent for RFA-MH-23-265 "Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed)"
  (NOT-MH-23-320)
  National Institute of Mental Health
  

• Notice of the Extension of the Expiration Date for NOT-OD-23-040: Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
  (NOT-OD-23-130)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Small Research Grants for Innovations in Healthy Longevity Research
  (NOT-AG-23-027)
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
  (NOT-MH-23-250)
  National Institute of Mental Health
  

Funding Opportunities

• Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
  (PAR-23-151)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute on Drug Abuse
  Application Receipt Date(s): August 09, 2023
  
  

• NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
  (PAR-23-183)
  National Library of Medicine
  Application Receipt Date(s): February 26, 2026
  
  

• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PAR-23-185)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 18, 2023
  
  

• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-23-186)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 18, 2023
  
  

• Alcohol Treatment and Recovery Research (R01 Clinical Trial Required)
  (PAR-23-187)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 18, 2023
  
  

• Alcohol Treatment and Recovery Research (R34 Clinical Trial required)
  (PAR-23-188)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 18, 2023
  
  

• Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
  (PAR-23-193)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): October 3, 2023, April 3, 2024, October 3, 2024, April 3, 2025, October 3, 2025, April 3, 2026
  
  

• Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-021)
  National Institute on Aging
  Application Receipt Date(s): October 23, 2023
  
  

• Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-022)
  National Institute on Aging
  Application Receipt Date(s): October 23, 2023
  
  

• Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-023)
  National Institute on Aging
  Application Receipt Date(s): October 23, 2023
  
  

• Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
  (RFA-AG-24-036)
  National Institute on Aging
  Application Receipt Date(s): October 23, 2023
  
  

• Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)
  (RFA-AG-24-038)
  National Institute on Aging
  Application Receipt Date(s): October 23, 2023
  
  

• Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-029)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
  (RFA-AI-23-032)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 25, 2023
  
  

• Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional)
  (RFA-DA-24-016)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 02, 2023
  
  

• Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required)
  (RFA-DA-24-024)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 02, 2023
  
  

• Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
  (RFA-DA-24-028)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 02, 2023
  
  

• Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required)
  (RFA-DA-24-029)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 02, 2023
  
  

• Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed)
  (RFA-DK-23-009)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 26, 2023
  
  

• Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed)
  (RFA-DK-23-010)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 26, 2023
  
  

• Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)
  (RFA-HD-24-005)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Application Receipt Date(s): August 07, 2023
  
  

• Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
  (RFA-NS-23-027)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed)
  (RFA-NS-24-003)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): July 28, 2023
  
  

• Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
  (RFA-NS-24-010)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): September 08, 2023